Department of Surgery, Yale School of Medicine, New Haven, CT.
National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
J Am Coll Surg. 2019 Jun;228(6):839-851. doi: 10.1016/j.jamcollsurg.2019.02.050. Epub 2019 Mar 19.
Surgical management of appendiceal carcinoid tumors is heavily debated, despite National Comprehensive Cancer Network guidelines recommending aggressive resection of tumors >2 cm. We investigated national practice patterns and the predictors and impact of guideline non-adherence.
The National Cancer Database was queried for cases of appendiceal carcinoids diagnosed from 2004 to 2015 treated with either appendectomy or hemicolectomy. Multivariable logistic regression, adjusted for demographic and clinical factors, identified associations with the procedure type among patients stratified by tumor size ≤2 cm and >2 cm. Cox Proportional Hazards then identified associations with overall survival among stratified patient groups.
Of 3,198 cases of appendiceal carcinoids, 1,893 appendectomies and 1,305 hemicolectomies were identified. Contrary to National Comprehensive Cancer Network guidelines, 32.4% of tumors ≤2 cm were treated with hemicolectomy and 31.3% of tumors >2 cm were treated with definitive appendectomy. Hemicolectomy for small tumors was associated with age 65 years and older (odds ratio [OR] 2.4; 95% CI 1.7 to 3.3; reference group age 18 to 39 years), history of malignancy (OR 2.0; 95% CI 1.6 to 2.6), tumor size 1.1 to 2 cm (OR 2.8; 95% CI 2.3 to 3.4; reference group size ≤1 cm), and lymphovascular invasion (OR 2.2; 95% CI 1.6 to 3.2); appendectomy for large tumors was associated with age 65 years and older only (OR 2.2; 95% CI 1.1 to 4.2). Procedure type was not associated with survival for small or large tumors (hazard ratio 1.0; 95% CI 0.7 to 1.4 and hazard ratio 1.1; 95% CI 0.6 to 2.0, respectively).
Despite well-known size-based treatment guidelines for appendiceal carcinoids, one-third of patients in the US undergo hemicolectomy for small tumors and appendectomy for large tumors. Guideline non-adherence, however, is not associated with overall survival. Reasons for these practice patterns should be explored, and guidelines revisited.
尽管国家综合癌症网络指南建议积极切除>2cm 的肿瘤,但阑尾类癌肿瘤的手术治疗仍存在很大争议。我们调查了全国的实践模式,以及指南不依从的预测因素和影响。
从 2004 年至 2015 年,国家癌症数据库对诊断为阑尾类癌并接受阑尾切除术或半结肠切除术治疗的病例进行了检索。多变量逻辑回归,调整了人口统计学和临床因素,确定了在肿瘤大小≤2cm 和>2cm 的患者中,与手术类型相关的因素。然后,Cox 比例风险模型确定了分层患者群体的总生存与这些因素的关系。
在 3198 例阑尾类癌中,确定了 1893 例阑尾切除术和 1305 例半结肠切除术。与国家综合癌症网络指南相反,32.4%的≤2cm 肿瘤采用半结肠切除术治疗,31.3%的>2cm 肿瘤采用确定性阑尾切除术治疗。对于小肿瘤,半结肠切除术与年龄 65 岁及以上(比值比[OR]2.4;95%CI1.7 至 3.3;参考组年龄 18 至 39 岁)、恶性肿瘤病史(OR2.0;95%CI1.6 至 2.6)、肿瘤大小 1.1 至 2cm(OR2.8;95%CI2.3 至 3.4;参考组肿瘤大小≤1cm)和血管淋巴管侵犯(OR2.2;95%CI1.6 至 3.2)有关;对于大肿瘤,仅与年龄 65 岁及以上有关(OR2.2;95%CI1.1 至 4.2)。手术类型与小肿瘤或大肿瘤的生存均无相关性(小肿瘤的风险比为 1.0;95%CI0.7 至 1.4,大肿瘤的风险比为 1.1;95%CI0.6 至 2.0)。
尽管美国对阑尾类癌有基于肿瘤大小的明确治疗指南,但三分之一的患者接受半结肠切除术治疗小肿瘤,而接受阑尾切除术治疗大肿瘤。然而,指南不依从与总体生存率无关。应该探讨这些实践模式的原因,并重新审视指南。